Lymphangioma, any site
ICD-10 D18.1 is a billable code used to indicate a diagnosis of lymphangioma, any site.
Lymphangiomas are benign tumors that arise from the lymphatic vessels and can occur in various anatomical locations, including the skin, subcutaneous tissue, and deeper structures. These neoplasms are characterized by the proliferation of lymphatic endothelial cells, leading to the formation of cystic or solid masses filled with lymphatic fluid. Lymphangiomas are most commonly diagnosed in children, although they can occur at any age. Clinically, they may present as soft, compressible swellings that can vary in size and may be associated with other vascular anomalies. While lymphangiomas are generally benign, they can cause complications depending on their size and location, such as obstruction of lymphatic drainage or cosmetic concerns. Surveillance is often recommended to monitor for changes in size or symptoms, particularly in cases where the lymphangioma is located near vital structures. Although malignant transformation is rare, there is a potential for lymphangiomas to be associated with other malignancies, necessitating careful evaluation and management.
Detailed history and physical examination notes, including size, location, and symptoms of the lymphangioma.
Diagnosis of lymphangioma in infants or children presenting with soft tissue masses.
Consideration of growth patterns and potential for intervention.
Photographic evidence of lesions, detailed descriptions of the morphology and location.
Evaluation of cutaneous lymphangiomas and their management.
Documentation of cosmetic concerns and treatment options.
Used for diagnostic evaluation of lymphangiomas.
Document the indication for imaging and findings.
Pediatric specialists may require additional imaging for growth monitoring.
Surgical excision of a lymphangioma.
Document the size, location, and reason for excision.
Ensure clear documentation of the surgical approach and pathology results.
Treatment options for lymphangioma may include observation, sclerotherapy, or surgical excision, depending on the size, location, and symptoms associated with the lesion.
While lymphangiomas are benign, there is a rare potential for them to be associated with malignancies, necessitating careful monitoring and evaluation.
